With a quantity of roughly USD 24bn, US biotech firms have already raised extra enterprise capital within the first three quarters of 2021 than in the entire 12 months 2020 (USD 22.4bn). In comparison with the primary … Learn extra
The publish Cumulated US Biotech Enterprise Capital Funding exceeds complete quantity of 2020 already within the third quarter of 2021 appeared first on FCF Fox Company Finance GmbH.